Vestmark Advisory Solutions Inc. Raises Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Vestmark Advisory Solutions Inc. increased its stake in Intuitive Surgical, Inc. by 95.0%, owning 17,144 shares worth approximately $8.49 million at the end of the first quarter.
• Insider sales included Gary S. Guthart selling 2,800 shares for a total of $1.39 million, resulting in a 13.13% decrease in his holdings.
• Intuitive Surgical's stock opened at $477.08 with a market cap of $171.02 billion, and analysts have varying price targets, with the consensus target being around $595.95.

Vestmark Advisory Solutions Inc. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 95.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,144 shares of the medical equipment provider's stock after acquiring an additional 8,350 shares during the quarter. Vestmark Advisory Solutions Inc.'s holdings in Intuitive Surgical were worth $8,491,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the last quarter. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $26,000. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter worth $26,000. Finally, LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the first quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ISRG shares. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their target price for the company from $515.00 to $440.00 in a research report on Monday, June 9th. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Piper Sandler restated an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, UBS Group upped their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $595.95.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 7,893 shares of the company's stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the sale, the insider directly owned 13,187 shares in the company, valued at $6,575,565.68. This trade represents a 37.44% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock valued at $7,896,972 over the last quarter. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.7%

ISRG traded up $3.18 during trading on Friday, hitting $480.26. 1,436,064 shares of the stock were exchanged, compared to its average volume of 2,169,233. The firm has a market capitalization of $172.16 billion, a P/E ratio of 66.98, a PEG ratio of 5.03 and a beta of 1.59. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a fifty day moving average price of $508.75 and a two-hundred day moving average price of $524.77.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.